Segall Bryant & Hamill LLC Has $2.31 Million Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Segall Bryant & Hamill LLC cut its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 51.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 17,379 shares of the company's stock after selling 18,134 shares during the period. Segall Bryant & Hamill LLC owned about 0.10% of Addus HomeCare worth $2,312,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Ellsworth Advisors LLC purchased a new stake in Addus HomeCare in the 2nd quarter worth approximately $598,000. Quadrature Capital Ltd bought a new stake in Addus HomeCare during the 1st quarter valued at about $1,557,000. SG Americas Securities LLC bought a new position in Addus HomeCare in the second quarter worth approximately $842,000. Dimensional Fund Advisors LP increased its position in Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company's stock valued at $82,930,000 after purchasing an additional 5,421 shares during the period. Finally, Point72 Asset Management L.P. raised its position in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock worth $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of analyst reports. TD Cowen increased their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a "buy" rating in a report on Thursday, August 8th. Royal Bank of Canada reiterated an "outperform" rating and set a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp assumed coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an "overweight" rating and a $150.00 target price on the stock. Macquarie reiterated an "outperform" rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Stephens raised their price objective on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $131.63.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 75.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now directly owns 3,366 shares of the company's stock, valued at approximately $429,165. The trade was a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. Company insiders own 4.60% of the company's stock.

Addus HomeCare Stock Up 2.9 %

Shares of Addus HomeCare stock traded up $3.48 during trading on Friday, reaching $124.32. The company's stock had a trading volume of 154,539 shares, compared to its average volume of 136,408. Addus HomeCare Co. has a 12-month low of $85.43 and a 12-month high of $136.12. The company has a market capitalization of $2.25 billion, a P/E ratio of 28.45, a price-to-earnings-growth ratio of 2.11 and a beta of 1.04. The business has a 50 day moving average price of $128.25 and a 200-day moving average price of $123.29.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare's revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.03 earnings per share. Research analysts predict that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.